Mas Mehmet-Refik, Comert Bilgin, Mas Nuket, Yamanel Levent, Ozotuk Haluk, Tasci Ilker, Jazrawi Riadh-P
Department of Internal Medicine, Gülhane School of Medicine, GATA Ic Hasta-liklari B.D., Etlik 06018 Ankara, Turkey.
World J Gastroenterol. 2007 Aug 28;13(32):4336-9. doi: 10.3748/wjg.v13.i32.4336.
To evaluate ursodeoxycholic acid (UDCA) therapy on the in vitro contraction of gallbladder smooth muscle strips from cholesterol gallstone patients.
The contraction forces of gallbladder smooth muscle strips from 28 patients with cholesterol gallstones treated with UDCA were compared with contraction forces from 14 untreated patients. The strips were stimulated with increasing concentrations of cholecystokinin-8 (CCK-8).
Although the contraction forces that developed in response to CCK-8 were higher in strips from specimens of UDCA treated patients compared to untreated patients, longer treatment periods (6-wk) caused more contraction responses than the short treatment period of 3-wk (F = 19.297, 1.85 +/- 0.22 g vs 1.70 +/- 0.10 g, P < 0.01). Contraction forces developed with maximal stimulation with KCl in the 6-wk treatment group were also higher than contraction forces in the untreated group (F = 4.274, 3.77 +/- 0.45 g vs 3.30 +/- 0.30 g, P < 0.05).
Six-week UDCA treatment caused an increase in contractions of muscle strips from patients with cholesterol gallstones when compared to shorter treatment administration or controls. We suggest that extending UDCA treatment periods may cause more effective contractions in the gallbladder, and thereby increase the rate of response to treatment.
评估熊去氧胆酸(UDCA)治疗对胆固醇结石患者胆囊平滑肌条体外收缩的影响。
将28例接受UDCA治疗的胆固醇结石患者的胆囊平滑肌条收缩力与14例未治疗患者的收缩力进行比较。用递增浓度的胆囊收缩素-8(CCK-8)刺激这些肌条。
尽管与未治疗患者相比,接受UDCA治疗患者标本的肌条对CCK-8产生的收缩力更高,但较长的治疗期(6周)比较短的3周治疗期引起更多的收缩反应(F = 19.297,1.85±0.22克对1.70±0.10克,P < 0.01)。6周治疗组用氯化钾最大刺激产生的收缩力也高于未治疗组(F = 4.274,3.77±0.45克对3.30±0.30克,P < 0.05)。
与较短治疗期或对照组相比,六周的UDCA治疗使胆固醇结石患者的肌条收缩增加。我们认为延长UDCA治疗期可能会使胆囊产生更有效的收缩,从而提高治疗反应率。